PIK3CA and esophageal squamous cell carcinoma: As PI3K sits in the centre of complex signalling pathways and the coexistence of multiple genetic alterations in ESCC, the efficacy of PI3Kα inhibitors is often attenuated by concurrent oncogenic signalling pathways.